CN102872261B - 毛酸浆在制备治疗急性胆囊炎的药物中的应用 - Google Patents
毛酸浆在制备治疗急性胆囊炎的药物中的应用 Download PDFInfo
- Publication number
- CN102872261B CN102872261B CN201210360564.7A CN201210360564A CN102872261B CN 102872261 B CN102872261 B CN 102872261B CN 201210360564 A CN201210360564 A CN 201210360564A CN 102872261 B CN102872261 B CN 102872261B
- Authority
- CN
- China
- Prior art keywords
- medicine
- physalis pubescens
- preparation
- cholecystitis
- physalis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 240000006285 Physalis pubescens Species 0.000 title claims abstract description 78
- 235000009230 Physalis pubescens Nutrition 0.000 title claims abstract description 77
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims abstract description 52
- 201000001352 cholecystitis Diseases 0.000 title claims abstract description 49
- 208000000197 Acute Cholecystitis Diseases 0.000 title claims description 13
- 206010008614 Cholecystitis acute Diseases 0.000 title claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000004876 Physalis pruinosa Nutrition 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 10
- 239000000571 coke Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 abstract description 18
- 239000000284 extract Substances 0.000 abstract description 12
- 239000002552 dosage form Substances 0.000 abstract description 9
- 238000002481 ethanol extraction Methods 0.000 abstract description 4
- 238000003809 water extraction Methods 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000007547 defect Effects 0.000 abstract 1
- 210000000232 gallbladder Anatomy 0.000 description 15
- 239000002253 acid Substances 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 210000001015 abdomen Anatomy 0.000 description 10
- 241001164374 Calyx Species 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000825 pharmaceutical preparation Substances 0.000 description 7
- 235000014347 soups Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 5
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- -1 flavone compounds Chemical class 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 208000000003 Breakthrough pain Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 241000218176 Corydalis Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 239000007919 dispersible tablet Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229960002179 ephedrine Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 210000000224 granular leucocyte Anatomy 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 241000746375 Andrographis Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010004663 Biliary colic Diseases 0.000 description 1
- 241000270299 Boa Species 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000034702 Multiple pregnancies Diseases 0.000 description 1
- 206010029379 Neutrophilia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000721454 Pemphigus Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 238000012084 abdominal surgery Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000010271 massa medicata fermentata Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000008812 xiaoyanlidan Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210360564.7A CN102872261B (zh) | 2012-09-26 | 2012-09-26 | 毛酸浆在制备治疗急性胆囊炎的药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210360564.7A CN102872261B (zh) | 2012-09-26 | 2012-09-26 | 毛酸浆在制备治疗急性胆囊炎的药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102872261A CN102872261A (zh) | 2013-01-16 |
CN102872261B true CN102872261B (zh) | 2016-03-16 |
Family
ID=47473931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210360564.7A Expired - Fee Related CN102872261B (zh) | 2012-09-26 | 2012-09-26 | 毛酸浆在制备治疗急性胆囊炎的药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102872261B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103417745B (zh) * | 2013-08-05 | 2015-04-22 | 张艳 | 一种治疗急性胆囊炎的中药制剂及其制备方法 |
CN103610029B (zh) * | 2013-11-28 | 2015-05-13 | 东北农业大学 | 一种毛酸浆果实中黄色素的提取方法 |
CN104189163A (zh) * | 2014-08-21 | 2014-12-10 | 李芝芳 | 一种治疗胆囊炎的中药配方 |
CN104524473A (zh) * | 2015-01-15 | 2015-04-22 | 王金强 | 一种治疗胆管结石的药物制剂及制法 |
CN104740009A (zh) * | 2015-03-16 | 2015-07-01 | 鄢明亮 | 一种治疗慢性胆囊炎的中药制剂及制备方法 |
CN105106821A (zh) * | 2015-09-23 | 2015-12-02 | 董春年 | 一种治疗胆囊炎的中药制剂 |
CN112957402A (zh) * | 2021-04-22 | 2021-06-15 | 黑龙江中医药大学 | 治疗肝胆湿热的药物制剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1320399A (zh) * | 2001-04-24 | 2001-11-07 | 刘秀才 | 红姑娘汁饮料及其制备方法 |
CN101244153A (zh) * | 2008-02-01 | 2008-08-20 | 张炯怡 | 酸浆在制备治疗消化系统疾病的药物中的应用、产品和制备 |
-
2012
- 2012-09-26 CN CN201210360564.7A patent/CN102872261B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1320399A (zh) * | 2001-04-24 | 2001-11-07 | 刘秀才 | 红姑娘汁饮料及其制备方法 |
CN101244153A (zh) * | 2008-02-01 | 2008-08-20 | 张炯怡 | 酸浆在制备治疗消化系统疾病的药物中的应用、产品和制备 |
Also Published As
Publication number | Publication date |
---|---|
CN102872261A (zh) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102872261B (zh) | 毛酸浆在制备治疗急性胆囊炎的药物中的应用 | |
CN105749179A (zh) | 治疗代谢综合征的中药组合物 | |
CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
CN101569739B (zh) | 一种治疗胆囊炎的中药组合物及其制备方法 | |
CN105535471A (zh) | 一种用于治疗神经衰弱的丸剂药物及其制备方法 | |
CN103301400A (zh) | 一种治疗慢性萎缩性胃炎的中药组合物及制备方法 | |
CN101249240B (zh) | 一种治疗习惯性流产的固本安胎液及其制备方法 | |
CN101658657B (zh) | 一种用于治疗慢性胆囊炎的药物 | |
CN104043050A (zh) | 一种治疗胆囊炎的中药组合物 | |
CN105497780A (zh) | 和胃护膜止痛汤 | |
CN100579544C (zh) | 一种治疗胆囊炎、胆结石的中药制剂及其制备方法 | |
CN100431595C (zh) | 用于气滞寒凝胃痛的药物组合物及其制备方法和用途 | |
WO2019104931A1 (zh) | 一种治疗白血病的中药组合物及其制备方法 | |
CN103041233A (zh) | 一种治疗小儿腹泻的药物组合物及其制备方法 | |
CN103550548B (zh) | 一种治疗便秘的中药组合物 | |
CN102631619A (zh) | 一组治疗慢性浅表性胃炎的中药 | |
CN101579507B (zh) | 一种治疗胆结石的药物及其制备方法 | |
CN104491316B (zh) | 一种治疗中气不足型前列腺增生症的中药制剂 | |
CN103585206A (zh) | 一种金腰草提取物的制备方法及其应用 | |
CN105362835A (zh) | 一种治疗功能性消化不良的中药组合物 | |
CN105709005A (zh) | 一种乳康丸 | |
CN104383025B (zh) | 一种用于治疗慢性风湿性心脏病的中药 | |
CN104826068A (zh) | 一种祛风除湿的药物及其制备方法 | |
CN104758888A (zh) | 一种治疗消渴病的中药组合物 | |
CN103349749B (zh) | 治疗高脂血症的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Bingshou Inventor after: Liu Lin Inventor after: Li Junfeng Inventor after: Li Xiaoming Inventor after: Li Zhe Inventor after: Lu Jian Inventor before: Kong Qianqian Inventor before: Shao Chengming Inventor before: Pang Dakun |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160205 Address after: Zhang Zhuang Lu, Huaiyin District of Ji'nan city of Shandong Province, No. 104, No. 1 Building 2 unit 202 Applicant after: Li Bingshou Address before: 250101 No. 51 Industrial South Road, Shandong, Ji'nan Applicant before: Jinan Xingyi Medical Technology Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160316 Termination date: 20160926 |